Stryker Unit Pleads Guilty To Illegal Sale of Knee Surgery Cutting Guides
OtisMed, a subsidiary of Stryker Corp. has agreed to pay $80 million in fines and penalties for illegally selling knee surgery cutting guides without the FDA's approval.
OtisMed, a subsidiary of Stryker Corp. has agreed to pay $80 million in fines and penalties for illegally selling knee surgery cutting guides without the FDA's approval.
Stryker faces a lawsuit from a woman who says its recalled ShapeMatch Cutting Guides left her with an ill-fitting knee replacement that will likely have to be replaced.